Structured comparisons to help researchers understand the differences between commonly discussed compounds. We cover mechanism, evidence quality, and practical considerations — not sales copy.
8 Articles
Nasal sprays and subcutaneous injections are the two primary delivery methods for research peptides. This guide compares bioavailability, speed of onset, which peptides suit each method, and the practical differences for regular use.
BPC-157 and TB-500 are both recovery peptides but work through entirely different mechanisms. This comparison covers how each works, what the research shows, their practical differences, and whether combining them makes sense.
GHK-Cu is a copper-binding tripeptide that activates collagen synthesis pathways. Collagen supplements provide amino acid building blocks. They work at different levels and are not equivalent. Here is how they compare.
MOTS-c is a mitochondrial-derived signalling peptide. NAD+ is a coenzyme restored through oral precursors. Both affect mitochondrial function but through different mechanisms. Here is a clear side-by-side comparison.
Tirzepatide is a dual GLP-1/GIP agonist approved for type 2 diabetes and obesity. Retatrutide adds a third receptor — glucagon — making it a triple agonist with greater weight loss in Phase 2 trials. This article compares mechanism, evidence, and practical differences.
Semax is stimulating and BDNF-upregulating. Selank is calming and anxiolytic. Both are Russian-developed cognitive peptides with different profiles. This comparison explains when each is studied and why they are sometimes combined.
SS-31 (Elamipretide) and MOTS-c both target mitochondria but through completely different mechanisms. SS-31 is a cardiolipin-binding antioxidant. MOTS-c is a mitochondrial-derived signalling peptide. Here is how they differ.
Tesamorelin is an FDA-approved GHRH analogue for HIV-associated lipodystrophy. CJC-1295 with Ipamorelin is a popular GH secretagogue combination. Here is how their mechanisms, evidence, and practical profiles compare.
